Luo et al. (2018) found that liver tissues from patients with non‐alcoholic fatty liver disease and mice with HFD‐induced steatosis expressed higher levels of STING, while STING inhibition in macrophages decreased the inflammation and the severity of the liver fibrosis. The gene discussed is STING1; the disease is metabolic dysfunction-associated steatotic liver disease.